Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Angina Global Market Report 2025
Download Free Sample Buy Now
Global Angina Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Angina Global Market Report 2025

By Type (Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types), By Treatment (Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments), By Drug Class (Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes), By Application (Clinics, Hospitals, Other Applications) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Angina Market Overview

• Angina market size has reached to $10.71 billion in 2024

• Expected to grow to $14.18 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%

• Growth Driver: The Rising Prevalence of Coronary Artery Disease A Catalyst For Growth In The Angina Market

• Market Trend: Pharmaceutical Companies Innovate With Metoprolol Tartrate Tablets To Enhance Treatment For Coronary Artery Disease And Related Conditions

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Angina Market?

Angina, also known as angina pectoris, is a medical condition characterized by chest pain or discomfort, typically caused by insufficient blood flow to the heart muscle. It inadequate blood flow is usually a result of blockages or narrowing of the coronary arteries due to atherosclerosis.

The main types of angina are angina pectoris, unstable angina, prinzmetal angina, and others. Angina pectoris, a medical condition associated with coronary heart disease, manifests as chest discomfort or pain due to insufficient blood supply to the heart, often attributed to blockages in the heart's arteries. The different types of treatment include lifestyle changes, medications, angioplasty and stenting, coronary bypass surgery, others with various drug classes such as beta-blockers, nitrates, and calcium channel blockers, angiotensin-converting enzyme inhibitors, others that are used in multiple applications such as Clinics, hospitals, and others.

Angina Market Size and growth rate 2025 to 2029: Graph

What Is The Angina Market Size 2025 And Growth Rate?

The angina market size has grown strongly in recent years. It will grow from $10.71 billion in 2024 to $11.36 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to increased prevalence of coronary heart disease, increased use of vasodilators, increased prevalence of myocardial ischemia, improved diagnostic capabilities, increased use of imaging techniques.

What Is The Angina Market Growth Forecast?

The angina market size is expected to see strong growth in the next few years. It will grow to $14.18 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to increasing prevalence of chronic angina pectoris, rising drug approvals and clinical research, increasing demand for retail pharmacies, growing awareness of cardiovascular health, growing demand for medications. Major trends in the forecast period include technological advancements in early diagnosis, advancements in angioplasty and stenting, new gene therapy approaches, demand for coronary stents, advancements in coronary artery disease treatment.

The forecast of 5.7% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. cardiology patients by driving up the cost of nitroglycerin patches and ranolazine tablets sourced from Israel and Germany, exacerbating chronic condition management costs and reducing medication adherence. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Angina Market Segmented?

1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types

2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments

3) By Drug Class: beta blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes

4) By Application: Clinics, Hospitals, Other Applications

Subsegments:

1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina

2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina

3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina

4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease

What Is Driving The Angina Market? The Rising Prevalence of Coronary Artery Disease A Catalyst For Growth In The Angina Market

The rising cases of coronary artery diseases are expected to propel the growth of the angina market going forward. Coronary artery disease (CAD), also known as coronary heart disease (CHD) or ischemic heart disease (IHD), is a condition characterized by the narrowing or blockage of the coronary arteries, which supply blood, oxygen, and nutrients to the heart muscle. The rising cases of coronary artery disease (CAD) are due to lifestyle changes and environmental and genetic factors. Angina plays a critical role in identifying and understanding the prevalence of coronary artery disease. Its presence prompts medical evaluation and diagnosis, helps stratify risk, guides treatment decisions, and informs public health strategies. For instance, in January 2023, according to the American Heart Association, from 2021 to 2022, the number of adults living with Coronary artery disease (CAD) in the U.S. rose from 18.2 million to approximately 19.3 million. Therefore, rising cases of coronary artery diseases drive the angina industry.

Who Are The Major Players In The Global Angina Market?

Major companies operating in the angina market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., Bayer AG, Sanofi S.A., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott laboratories, GlaxoSmithKline Plc, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd, Amgen Inc., Dr. Reddy's Laboratories, ViroMed Co. Ltd., Lee’s Pharmaceutical Holdings, Kuhnil Pharmaceutical, LegoChem Biosciences, Axus Cardium Pharmaceuticals, Juventas Therapeutics, Milestone Pharmaceuticals

What Are The Key Trends Of The Global Angina Market? Pharmaceutical Companies Innovate With Metoprolol Tartrate Tablets To Enhance Treatment For Coronary Artery Disease And Related Conditions

Major companies operating in the angina market are developing innovative drugs such as metoprolol tartrate tablets to provide more effective and targeted treatments for patients who have coronary artery disease (CAD) and related conditions. Metoprolol tartrate tablets are a form of medication commonly used to treat various cardiovascular conditions, including angina (chest pain), hypertension (high blood pressure), and heart failure. For instance, in April 2023, Zydus, an India-based pharmaceutical company, received final approval from the United States Food and Drug Administration (US-FDA) to manufacture and market its generic version of Metoprolol Tartrate Tablets USP in strengths of 25 mg, 50 mg, and 100 mg. Metoprolol is a beta blocker used to treat various cardiovascular conditions, including high blood pressure (hypertension) and chest pain (angina), and to improve survival after a heart attack.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Angina Market? Novo Nordisk Acquires Cardior Pharmaceuticals To Expand Cardiovascular Disease Portfolio

In March 2024, Novo Nordisk, a Denmark-based healthcare company, acquired Cardior Pharmaceuticals for $1.10 billion(€1.025 billion). This acquisition aims to strengthen Novo Nordisk's pipeline in cardiovascular disease management by incorporating Cardior's RNA-based therapeutics, particularly CDR132L, currently in Phase II clinical trials for treating heart failure. Cardior Pharmaceuticals is a Germany-based company that offers angiotensin-converting enzyme inhibitors.

What Is The Regional Outlook For The Global Angina Market?

North America was the largest region in the angina market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Angina Market?

The angina market consists of revenues earned by entities by providing treatments for stable angina, and microvascular angina. The market value includes the value of related goods sold by the service provider or included within the service offering. The angina market also includes sales of anticoagulants and statins. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Angina Industry?

The angina market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the angina industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Angina Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $11.36 billion
Revenue Forecast In 2034 $14.18 billion
Growth Rate CAGR of 5.7% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types
2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments
3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes
4) By Application: Clinics, Hospitals, Other Applications Subsegments: 1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina
2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina
3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina
4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., Bayer AG, Sanofi S.A., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott laboratories, GlaxoSmithKline Plc, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd, Amgen Inc., Dr. Reddy's Laboratories, ViroMed Co. Ltd., Lee’s Pharmaceutical Holdings, Kuhnil Pharmaceutical, LegoChem Biosciences, Axus Cardium Pharmaceuticals, Juventas Therapeutics, Milestone Pharmaceuticals
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Angina Market Characteristics

3. Angina Market Trends And Strategies

4. Angina Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Angina Growth Analysis And Strategic Analysis Framework

5.1. Global Angina PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Angina Market Growth Rate Analysis

5.4. Global Angina Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Angina Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Angina Total Addressable Market (TAM)

6. Angina Market Segmentation

6.1. Global Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Angina Pectoris

Unstable Angina

Prinzmetal Angina

Other Types

6.2. Global Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Lifestyle Changes

Medications

Angioplasty And Stenting

Coronary Bypass Surgery

Other Treatments

6.3. Global Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Beta Blockers

Nitrates And Calcium Channel Blockers

Angiotensin-Converting Enzyme Inhibitors

Other Drug Classes

6.4. Global Angina Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Clinics

Hospitals

Other Applications

6.5. Global Angina Market, Sub-Segmentation Of Angina Pectoris, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Stable Angina

Chronic Stable Angina

Effort-Induced Angina

Variant Or Microvascular Angina

6.6. Global Angina Market, Sub-Segmentation Of Unstable Angina, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Acute Unstable Angina

Pre-Infarction Angina

Rest Angina

6.7. Global Angina Market, Sub-Segmentation Of Prinzmetal Angina, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Vasospastic Angina

Coronary Artery Spasm-Induced Angina

Variant Angina

6.8. Global Angina Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Nocturnal Angina

Post-Infarction Angina

Angina With Silent Myocardial Ischemia

Angina Due To Aortic Stenosis Or Valve Disease

7. Angina Market Regional And Country Analysis

7.1. Global Angina Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Angina Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Angina Market

8.1. Asia-Pacific Angina Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Angina Market

9.1. China Angina Market Overview

9.2. China Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Angina Market

10.1. India Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Angina Market

11.1. Japan Angina Market Overview

11.2. Japan Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Angina Market

12.1. Australia Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Angina Market

13.1. Indonesia Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Angina Market

14.1. South Korea Angina Market Overview

14.2. South Korea Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Angina Market

15.1. Western Europe Angina Market Overview

15.2. Western Europe Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Angina Market

16.1. UK Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Angina Market

17.1. Germany Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Angina Market

18.1. France Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Angina Market

19.1. Italy Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Angina Market

20.1. Spain Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Angina Market

21.1. Eastern Europe Angina Market Overview

21.2. Eastern Europe Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Angina Market

22.1. Russia Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Angina Market

23.1. North America Angina Market Overview

23.2. North America Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Angina Market

24.1. USA Angina Market Overview

24.2. USA Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Angina Market

25.1. Canada Angina Market Overview

25.2. Canada Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Angina Market

26.1. South America Angina Market Overview

26.2. South America Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Angina Market

27.1. Brazil Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Angina Market

28.1. Middle East Angina Market Overview

28.2. Middle East Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Angina Market

29.1. Africa Angina Market Overview

29.2. Africa Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Angina Market Competitive Landscape And Company Profiles

30.1. Angina Market Competitive Landscape

30.2. Angina Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Angina Market Other Major And Innovative Companies

31.1. Sanofi S.A.

31.2. Novartis AG

31.3. Bristol-Myers Squibb Company

31.4. AstraZeneca PLC

31.5. Abbott laboratories

31.6. GlaxoSmithKline Plc

31.7. Eli Lilly and Company

31.8. Gilead Sciences Inc.

31.9. Teva Pharmaceutical Industries Ltd.

31.10. Otsuka Pharmaceutical Co. Ltd.

31.11. Troikaa Pharmaceuticals Ltd

31.12. Amgen Inc.

31.13. Dr. Reddy's Laboratories

31.14. ViroMed Co. Ltd.

31.15. Lee’s Pharmaceutical Holdings

32. Global Angina Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Angina Market

34. Recent Developments In The Angina Market

35. Angina Market High Potential Countries, Segments and Strategies

35.1 Angina Market In 2029 - Countries Offering Most New Opportunities

35.2 Angina Market In 2029 - Segments Offering Most New Opportunities

35.3 Angina Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Angina Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Angina Market, Sub-Segmentation Of Angina Pectoris, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Angina Market, Sub-Segmentation Of Unstable Angina, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Angina Market, Sub-Segmentation Of Prinzmetal Angina, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Angina Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Angina Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Angina Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Pfizer Inc. Financial Performance
  • Table 80: Johnson & Johnson Financial Performance
  • Table 81: F. Hoffmann-La Roche AG Financial Performance
  • Table 82: Merck & Co Inc. Financial Performance
  • Table 83: Bayer AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Angina Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Angina Market, Sub-Segmentation Of Angina Pectoris, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Angina Market, Sub-Segmentation Of Unstable Angina, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Angina Market, Sub-Segmentation Of Prinzmetal Angina, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Angina Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Angina Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Angina Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Angina Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Angina Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Pfizer Inc. Financial Performance
  • Figure 80: Johnson & Johnson Financial Performance
  • Figure 81: F. Hoffmann-La Roche AG Financial Performance
  • Figure 82: Merck & Co Inc. Financial Performance
  • Figure 83: Bayer AG Financial Performance

From Insight to Impact: Strategic Growth Mapping in the HER2-Positive Breast Cancer Market

Read More About From Insight to Impact: Strategic Growth Mapping in the HER2-Positive Breast Cancer Market

Hospital And Nursing Home Probiotics Market Overview 2025: Competitive Shifts, Forecast Models, and Emerging Opportunities

Read More About Hospital And Nursing Home Probiotics Market Overview 2025: Competitive Shifts, Forecast Models, and Emerging Opportunities

Next-Gen Implantable Cardioverter Defibrillators (ICDs) : Market Forecast, Transformation, and Long-Term Trajectories

Read More About Next-Gen Implantable Cardioverter Defibrillators (ICDs) : Market Forecast, Transformation, and Long-Term Trajectories

Indwelling Catheters Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Indwelling Catheters Growth Trajectory: Key Forecasts and Strategic Insights

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Explore the latest trends, growth insights, and forecasts in the Nutrition Analysis Software Global Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Nutrition Analysis Software Global Market.

Explore the latest trends, growth insights, and forecasts in the Global Wearable Fitness Trackers Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Global Wearable Fitness Trackers Market.

Angina Global Market Report 2025 – By Type (Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types), By Treatment (Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatm...

View Report

Angina Pectoris Drugs Global Market Report 2025 – By Drugs (Nitrates, Antiplatelet Agents, Beta-adrenergic Blocking Agents, Calcium Channel Blockers, Anti-ischemic Agents, Statins, Antihypertensive Agents, Other Drugs), ...

View Report

Angina Pectoris Drugs Global Market Report 2025 – By Drugs (Nitrates, Antiplatelet Agents, Beta-adrenergic Blocking Agents, Calcium Channel Blockers, Anti-ischemic Agents, Statins, Antihypertensive Agents, Other Drugs), ...

View Report

Angio Suites Global Market Report 2025 – By Type (Single-Plane, Bi-Plane), By Technology (X-ray Angiography, Computed Tomography (CT) Angiography, Magnetic Resonance Angiography (MRA), Other Technologies), By Application...

View Report

Coronary Artery Disease Global Market Report 2025 – By Treatment (Medication, Surgery, Additional Therapy, Other Treatments), By Diagnosis (Electrocardiogram, Echocardiogram, Stress Test, Cardiac Catheterization, Heart C...

View Report

Vascular Stent Global Market Report 2025 – By Product( Coronary Stents, Peripheral Vascular Stents, Ever Stent Grafts), By Type( Bare Metal Stent, Bio-engineered Stent, Bioresorbable Vascular Scaffold, Drug Eluting Stent...

View Report

Vascular Imaging Global Market Report 2025 – By Technique (Magnetic Resonance Imaging, Ultrasound, Computed Tomography, Nuclear Imaging, X-Ray), By Procedure (Coronary Angiography, Peripheral Angiography, Neurovascular A...

View Report

Hereditary Angioedema Therapeutics Global Market Report 2025 – By Drug Class (C1 Esterase Inhibitor, Selective Bradykinin B2 Receptor Antagonist, Kallikrein Inhibitor, Other Drug Classes), By Route of Administration (Int...

View Report

Frequently Asked Questions

Angina, also known as angina pectoris, is a medical condition characterized by chest pain or discomfort, typically caused by insufficient blood flow to the heart muscle. It inadequate blood flow is usually a result of blockages or narrowing of the coronary arteries due to atherosclerosis. For further insights on this market, request a sample here

The market major growth driver - The Rising Prevalence of Coronary Artery Disease A Catalyst For Growth In The Angina Market. For further insights on this market, request a sample here

The angina market size has grown strongly in recent years. It will grow from $10.71 billion in 2024 to $11.36 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to increased prevalence of coronary heart disease, increased use of vasodilators, increased prevalence of myocardial ischemia, improved diagnostic capabilities, increased use of imaging techniques. The angina market size is expected to see strong growth in the next few years. It will grow to " $14.18 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to increasing prevalence of chronic angina pectoris, rising drug approvals and clinical research, increasing demand for retail pharmacies, growing awareness of cardiovascular health, growing demand for medications. Major trends in the forecast period include technological advancements in early diagnosis, advancements in angioplasty and stenting, new gene therapy approaches, demand for coronary stents, advancements in coronary artery disease treatment. For further insights on this market, request a sample here

The anginamarket covered in this report is segmented –
1) By Type: Angina Pectoris; Unstable Angina; Prinzmetal Angina; Other Types
2) By Treatment: Lifestyle Changes; Medications; Angioplasty And Stenting; Coronary Bypass Surgery; Other Treatments
3) By Drug Class: Beta Blockers; Nitrates And Calcium Channel Blockers; Angiotensin-Converting Enzyme Inhibitors; Other Drug Classes
4) By Application: Clinics; Hospitals; Other Applications Subsegments:
1) By Angina Pectoris: Stable Angina; Chronic Stable Angina; Effort-Induced Angina; Variant Or Microvascular Angina
2) By Unstable Angina: Acute Unstable Angina; Pre-Infarction Angina; Rest Angina
3) By Prinzmetal Angina: Vasospastic Angina; Coronary Artery Spasm-Induced Angina; Variant Angina
4) By Other Types: Nocturnal Angina; Post-Infarction Angina; Angina With Silent Myocardial Ischemia; Angina Due To Aortic Stenosis Or Valve Disease For further insights on this market, request a sample here

North America was the largest region in the angina market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the angina market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., Bayer AG, Sanofi S.A., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott laboratories, GlaxoSmithKline Plc, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd, Amgen Inc., Dr. Reddy's Laboratories, ViroMed Co. Ltd., Lee’s Pharmaceutical Holdings, Kuhnil Pharmaceutical, LegoChem Biosciences, Axus Cardium Pharmaceuticals, Juventas Therapeutics, Milestone Pharmaceuticals. For further insights on this market, request a sample here.

Major trends in this market include Pharmaceutical Companies Innovate With Metoprolol Tartrate Tablets To Enhance Treatment For Coronary Artery Disease And Related Conditions. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Angina Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon